643 related articles for article (PubMed ID: 7474883)
1. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera].
Kozlov VG; Viktorova EG
Vopr Virusol; 2011; 56(2):41-6. PubMed ID: 21545042
[TBL] [Abstract][Full Text] [Related]
3. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.
Leenaars PP; Hendriksen CF; Angulo AF; Koedam MA; Claassen E
Vet Immunol Immunopathol; 1994 Mar; 40(3):225-41. PubMed ID: 8160361
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of pregnant guinea pigs with Campylobacter fetus: effects of antigen dose, Campylobacter strain, and adjuvant type.
Bryner JH; Firehammer BD; Wesley IV
Am J Vet Res; 1988 Apr; 49(4):449-55. PubMed ID: 3377303
[TBL] [Abstract][Full Text] [Related]
6. Immune responses and side effects of five different oil-based adjuvants in mice.
Leenaars M; Koedam MA; Hendriksen CF; Claassen E
Vet Immunol Immunopathol; 1998 Feb; 61(2-4):291-304. PubMed ID: 9613442
[TBL] [Abstract][Full Text] [Related]
7. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
[TBL] [Abstract][Full Text] [Related]
8. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.
Bernstein DI; Edwards KM; Dekker CL; Belshe R; Talbot HK; Graham IL; Noah DL; He F; Hill H
J Infect Dis; 2008 Mar; 197(5):667-75. PubMed ID: 18260764
[TBL] [Abstract][Full Text] [Related]
9. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
[TBL] [Abstract][Full Text] [Related]
10. Response of guinea pigs to a vaccine containing a new adjuvant (SAF) and gram-negative bacteria.
Houston L; Moncla BJ; Page R; Engel D
Lab Anim Sci; 1995 Feb; 45(1):59-66. PubMed ID: 7752616
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
[TBL] [Abstract][Full Text] [Related]
13. Pathological studies on local tissue reactions in guinea pigs and rats caused by four different adjuvants.
Yamanaka M; Hiramatsu K; Hirahara T; Okabe T; Nakai M; Sasaki N; Goto N
J Vet Med Sci; 1992 Aug; 54(4):685-92. PubMed ID: 1391179
[TBL] [Abstract][Full Text] [Related]
14. Effect of different adjuvants in equines for the production of equine rabies immunoglobulin.
Arora S; Sharma S; Goel SK; Singh US
Natl Med J India; 2005; 18(6):289-92. PubMed ID: 16483026
[TBL] [Abstract][Full Text] [Related]
15. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
[TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
17. The selection of an adjuvant emulsion for polyclonal antibody production using a low-molecular-weight antigen in rabbits.
Smith DE; O'Brien ME; Palmer VJ; Sadowski JA
Lab Anim Sci; 1992 Dec; 42(6):599-601. PubMed ID: 1479813
[TBL] [Abstract][Full Text] [Related]
18. MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.
El Sahly H
Expert Rev Vaccines; 2010 Oct; 9(10):1135-41. PubMed ID: 20923265
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits.
Johnston BA; Eisen H; Fry D
Lab Anim Sci; 1991 Jan; 41(1):15-21. PubMed ID: 1849580
[TBL] [Abstract][Full Text] [Related]
20. New hepatitis B vaccine formulated with an improved adjuvant system.
Kundi M
Expert Rev Vaccines; 2007 Apr; 6(2):133-40. PubMed ID: 17408363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
